Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sulfonamide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117603100B reveals a green one-pot synthesis route offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN114525527B details a metal-free electrochemical route for sultam derivatives, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Novel Wittig reaction route ensures high purity impurity standard for Rosuvastatin Calcium quality control and regulatory compliance supply chain.
Novel anti-tumor silybin derivatives via CN116444505A. Enhanced potency and scalable synthesis for pharmaceutical intermediates supply chain optimization.
Patent CN113105374A reveals a nickel-catalyzed method for alkylamine derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN109824665B details a novel oxidative coupling method for synthesizing imidazopyridine sulfonamides using methanol, offering cost-effective routes for pharmaceutical intermediates.
Patent CN105693621A details a novel oxidative sulfonylation method using stable sulfinate salts, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN111187219B reveals stable photocatalytic salt enabling cost reduction in pharmaceutical intermediates manufacturing and high-purity supply chain reliability.
Patent CN107739322B details a novel Ir-catalyzed C-H activation route for sulfonamides. Discover cost-effective, high-yield manufacturing solutions for pharma and agrochemical intermediates.
Novel preparation method avoids acyl chloride instability. Achieves >99.5% purity. Cost-effective API intermediate manufacturing solution for global supply chains.
Discover a novel preparation method for sulfonamide imidazolium salts enabling efficient photocatalytic radical generation for high-purity pharmaceutical intermediate manufacturing.
Patent CN114276280B reveals enzymatic route for chiral sulfonamide. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel iridium-catalyzed methylation route for TNNI3K inhibitors offers green chemistry benefits and scalable API intermediate manufacturing solutions.
Patent CN108690007B reveals a green C-H coupling method using ionic liquids. This technology offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN108610304B details a novel Pd-catalyzed C-H activation route for diaryl sultams, offering superior atom economy and simplified supply chains for pharmaceutical intermediates.
Novel green electrochemical route for 6-7-5 fused ring sulfonamides. Metal-free, mild conditions, scalable for high-purity pharmaceutical intermediates manufacturing.
Patent CN112920053A reveals a safer, high-yield route for chiral amines used in asthma and cancer drugs, offering significant cost reduction and supply chain reliability for API manufacturers.
This patent details a metal-free synthesis method for benzenesulfonamides using iodine catalysts. It offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes globally.
Patent CN108690007B details a transition metal-catalyzed C-H coupling method using ionic liquids for efficient ortho-cyanation, offering significant cost reduction in API manufacturing.
Patent CN112920053B reveals a scalable, high-purity route for chiral amines used in asthma and oncology APIs, offering significant cost and safety advantages.